Absci (ABSI) Non-Current Debt (2020 - 2025)
Absci's (ABSI) quarterly Non-Current Debt came in at $65000.0 in Q3 2025, down 96.98% year-on-year from $2.2 million in Q3 2024, and down 59.63% quarter-over-quarter from $161000.0 in Q2 2025.
Absci (ABSI) Non-Current Debt (2020 - 2025) Analysis & Trends
Absci has disclosed Non-Current Debt across 6 years of filings, most recently posting $65000.0 for Q3 2025.
- Non-Current Debt for Q3 2025 came in at $65000.0, down 96.98% year-over-year; the trailing twelve-month figure through Sep 2025 was $65000.0 (down 96.98% YoY), and the FY2024 annual result was $1.3 million, down 73.03% from the prior year.
- Non-Current Debt came in at $65000.0 for Q3 2025 at Absci, down from $161000.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $8.0 million in Q4 2022 to a low of $65000.0 in Q3 2025.
- The 5-year median for Non-Current Debt is $3.2 million (2021), against an average of $3.5 million.
- Across the five-year window, Non-Current Debt jumped 1254.05% in 2023 and plunged 96.98% in 2025, its largest moves.
- Absci's Non-Current Debt stood at $1.1 million in 2021, then soared by 610.32% to $8.0 million in 2022, then tumbled by 41.63% to $4.7 million in 2023, then tumbled by 73.03% to $1.3 million in 2024, then tumbled by 94.83% to $65000.0 in 2025.
- The last three Non-Current Debt figures came in at $65000.0 (Q3 2025), $161000.0 (Q2 2025), and $682000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 65,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | 682,000.00 |
| Mar 31, 2025 | 682,000.00 |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | 4.66 Mn |
| Dec 31, 2023 | 4.66 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 6.38 Mn |
| Jun 30, 2023 | 6.38 Mn |